Pre-order Enquiry
Request Free Sample
Global Opioid Induced Constipation Market Research Report 2022(Status and Outlook)
SKU ID : BOS-21146174 | Publishing Date : 22-Jun-2022 | No. of pages : 116
Detailed TOC of Global Opioid Induced Constipation Market Research Report 2022(Status and Outlook)
TABLE OF CONTENTS1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Opioid Induced Constipation
1.2 Key Market Segments
1.2.1 Opioid Induced Constipation Segment by Type
1.2.2 Opioid Induced Constipation Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Opioid Induced Constipation Market Overview
2.1 Global Market Overview
2.1.1 Global Opioid Induced Constipation Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Opioid Induced Constipation Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Opioid Induced Constipation Market Competitive Landscape
3.1 Global Opioid Induced Constipation Sales by Manufacturers (2017-2022)
3.2 Global Opioid Induced Constipation Revenue Market Share by Manufacturers (2017-2022)
3.3 Opioid Induced Constipation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Opioid Induced Constipation Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Opioid Induced Constipation Sales Sites, Area Served, Product Type
3.6 Opioid Induced Constipation Market Competitive Situation and Trends
3.6.1 Opioid Induced Constipation Market Concentration Rate
3.6.2 Global 5 and 10 Largest Opioid Induced Constipation Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Opioid Induced Constipation Industry Chain Analysis
4.1 Opioid Induced Constipation Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Opioid Induced Constipation Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Opioid Induced Constipation Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Opioid Induced Constipation Sales Market Share by Type (2017-2022)
6.3 Global Opioid Induced Constipation Market Size Market Share by Type (2017-2022)
6.4 Global Opioid Induced Constipation Price by Type (2017-2022)
7 Opioid Induced Constipation Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Opioid Induced Constipation Market Sales by Application (2017-2022)
7.3 Global Opioid Induced Constipation Market Size (M USD) by Application (2017-2022)
7.4 Global Opioid Induced Constipation Sales Growth Rate by Application (2017-2022)
8 Opioid Induced Constipation Market Segmentation by Region
8.1 Global Opioid Induced Constipation Sales by Region
8.1.1 Global Opioid Induced Constipation Sales by Region
8.1.2 Global Opioid Induced Constipation Sales Market Share by Region
8.2 North America
8.2.1 North America Opioid Induced Constipation Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Opioid Induced Constipation Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Opioid Induced Constipation Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Opioid Induced Constipation Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Opioid Induced Constipation Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 Takeda Pharmaceuticals
9.1.1 Takeda Pharmaceuticals Opioid Induced Constipation Basic Information
9.1.2 Takeda Pharmaceuticals Opioid Induced Constipation Product Overview
9.1.3 Takeda Pharmaceuticals Opioid Induced Constipation Product Market Performance
9.1.4 Takeda Pharmaceuticals Business Overview
9.1.5 Takeda Pharmaceuticals Opioid Induced Constipation SWOT Analysis
9.1.6 Takeda Pharmaceuticals Recent Developments
9.2 Bayer
9.2.1 Bayer Opioid Induced Constipation Basic Information
9.2.2 Bayer Opioid Induced Constipation Product Overview
9.2.3 Bayer Opioid Induced Constipation Product Market Performance
9.2.4 Bayer Business Overview
9.2.5 Bayer Opioid Induced Constipation SWOT Analysis
9.2.6 Bayer Recent Developments
9.3 Sanofi
9.3.1 Sanofi Opioid Induced Constipation Basic Information
9.3.2 Sanofi Opioid Induced Constipation Product Overview
9.3.3 Sanofi Opioid Induced Constipation Product Market Performance
9.3.4 Sanofi Business Overview
9.3.5 Sanofi Opioid Induced Constipation SWOT Analysis
9.3.6 Sanofi Recent Developments
9.4 Mallinckrodt
9.4.1 Mallinckrodt Opioid Induced Constipation Basic Information
9.4.2 Mallinckrodt Opioid Induced Constipation Product Overview
9.4.3 Mallinckrodt Opioid Induced Constipation Product Market Performance
9.4.4 Mallinckrodt Business Overview
9.4.5 Mallinckrodt Opioid Induced Constipation SWOT Analysis
9.4.6 Mallinckrodt Recent Developments
9.5 Salix (Bausch Health)
9.5.1 Salix (Bausch Health) Opioid Induced Constipation Basic Information
9.5.2 Salix (Bausch Health) Opioid Induced Constipation Product Overview
9.5.3 Salix (Bausch Health) Opioid Induced Constipation Product Market Performance
9.5.4 Salix (Bausch Health) Business Overview
9.5.5 Salix (Bausch Health) Opioid Induced Constipation SWOT Analysis
9.5.6 Salix (Bausch Health) Recent Developments
9.6 AstraZeneca
9.6.1 AstraZeneca Opioid Induced Constipation Basic Information
9.6.2 AstraZeneca Opioid Induced Constipation Product Overview
9.6.3 AstraZeneca Opioid Induced Constipation Product Market Performance
9.6.4 AstraZeneca Business Overview
9.6.5 AstraZeneca Recent Developments
9.7 Progenics Pharmaceuticals
9.7.1 Progenics Pharmaceuticals Opioid Induced Constipation Basic Information
9.7.2 Progenics Pharmaceuticals Opioid Induced Constipation Product Overview
9.7.3 Progenics Pharmaceuticals Opioid Induced Constipation Product Market Performance
9.7.4 Progenics Pharmaceuticals Business Overview
9.7.5 Progenics Pharmaceuticals Recent Developments
9.8 Purdue Pharm
9.8.1 Purdue Pharm Opioid Induced Constipation Basic Information
9.8.2 Purdue Pharm Opioid Induced Constipation Product Overview
9.8.3 Purdue Pharm Opioid Induced Constipation Product Market Performance
9.8.4 Purdue Pharm Business Overview
9.8.5 Purdue Pharm Recent Developments
9.9 Nektar Therapeutics
9.9.1 Nektar Therapeutics Opioid Induced Constipation Basic Information
9.9.2 Nektar Therapeutics Opioid Induced Constipation Product Overview
9.9.3 Nektar Therapeutics Opioid Induced Constipation Product Market Performance
9.9.4 Nektar Therapeutics Business Overview
9.9.5 Nektar Therapeutics Recent Developments
9.10 Daiichi Sankyo
9.10.1 Daiichi Sankyo Opioid Induced Constipation Basic Information
9.10.2 Daiichi Sankyo Opioid Induced Constipation Product Overview
9.10.3 Daiichi Sankyo Opioid Induced Constipation Product Market Performance
9.10.4 Daiichi Sankyo Business Overview
9.10.5 Daiichi Sankyo Recent Developments
9.11 Prestige
9.11.1 Prestige Opioid Induced Constipation Basic Information
9.11.2 Prestige Opioid Induced Constipation Product Overview
9.11.3 Prestige Opioid Induced Constipation Product Market Performance
9.11.4 Prestige Business Overview
9.11.5 Prestige Recent Developments
9.12 GSK
9.12.1 GSK Opioid Induced Constipation Basic Information
9.12.2 GSK Opioid Induced Constipation Product Overview
9.12.3 GSK Opioid Induced Constipation Product Market Performance
9.12.4 GSK Business Overview
9.12.5 GSK Recent Developments
9.13 Shionogi
9.13.1 Shionogi Opioid Induced Constipation Basic Information
9.13.2 Shionogi Opioid Induced Constipation Product Overview
9.13.3 Shionogi Opioid Induced Constipation Product Market Performance
9.13.4 Shionogi Business Overview
9.13.5 Shionogi Recent Developments
10 Opioid Induced Constipation Market Forecast by Region
10.1 Global Opioid Induced Constipation Market Size Forecast
10.2 Global Opioid Induced Constipation Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Opioid Induced Constipation Market Size Forecast by Country
10.2.3 Asia Pacific Opioid Induced Constipation Market Size Forecast by Region
10.2.4 South America Opioid Induced Constipation Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Opioid Induced Constipation by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Opioid Induced Constipation Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Opioid Induced Constipation by Type (2022-2028)
11.1.2 Global Opioid Induced Constipation Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Opioid Induced Constipation by Type (2022-2028)
11.2 Global Opioid Induced Constipation Market Forecast by Application (2022-2028)
11.2.1 Global Opioid Induced Constipation Sales (K Units) Forecast by Application
11.2.2 Global Opioid Induced Constipation Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings
List of Figures, Tables and Charts Available in Global Opioid Induced Constipation Market Research Report 2022(Status and Outlook)
LIST OF TABLESTable 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Opioid Induced Constipation Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Opioid Induced Constipation Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Opioid Induced Constipation Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Opioid Induced Constipation Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Opioid Induced Constipation Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Constipation as of 2021)
Table 10. Global Market Opioid Induced Constipation Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Opioid Induced Constipation Sales Sites and Area Served
Table 12. Manufacturers Opioid Induced Constipation Product Type
Table 13. Global Opioid Induced Constipation Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Opioid Induced Constipation
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Opioid Induced Constipation Market Challenges
Table 22. Market Restraints
Table 23. Global Opioid Induced Constipation Sales by Type (K Units)
Table 24. Global Opioid Induced Constipation Market Size by Type (M USD)
Table 25. Global Opioid Induced Constipation Sales (K Units) by Type (2017-2022)
Table 26. Global Opioid Induced Constipation Sales Market Share by Type (2017-2022)
Table 27. Global Opioid Induced Constipation Market Size (M USD) by Type (2017-2022)
Table 28. Global Opioid Induced Constipation Market Size Share by Type (2017-2022)
Table 29. Global Opioid Induced Constipation Price (USD/Unit) by Type (2017-2022)
Table 30. Global Opioid Induced Constipation Sales (K Units) by Application
Table 31. Global Opioid Induced Constipation Market Size by Application
Table 32. Global Opioid Induced Constipation Sales by Application (2017-2022) & (K Units)
Table 33. Global Opioid Induced Constipation Sales Market Share by Application (2017-2022)
Table 34. Global Opioid Induced Constipation Sales by Application (2017-2022) & (M USD)
Table 35. Global Opioid Induced Constipation Market Share by Application (2017-2022)
Table 36. Global Opioid Induced Constipation Sales Growth Rate by Application (2017-2022)
Table 37. Global Opioid Induced Constipation Sales by Region (2017-2022) & (K Units)
Table 38. Global Opioid Induced Constipation Sales Market Share by Region (2017-2022)
Table 39. North America Opioid Induced Constipation Sales by Country (2017-2022) & (K Units)
Table 40. Europe Opioid Induced Constipation Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Opioid Induced Constipation Sales by Region (2017-2022) & (K Units)
Table 42. South America Opioid Induced Constipation Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Opioid Induced Constipation Sales by Region (2017-2022) & (K Units)
Table 44. Takeda Pharmaceuticals Opioid Induced Constipation Basic Information
Table 45. Takeda Pharmaceuticals Opioid Induced Constipation Product Overview
Table 46. Takeda Pharmaceuticals Opioid Induced Constipation Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. Takeda Pharmaceuticals Business Overview
Table 48. Takeda Pharmaceuticals Opioid Induced Constipation SWOT Analysis
Table 49. Takeda Pharmaceuticals Recent Developments
Table 50. Bayer Opioid Induced Constipation Basic Information
Table 51. Bayer Opioid Induced Constipation Product Overview
Table 52. Bayer Opioid Induced Constipation Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Bayer Business Overview
Table 54. Bayer Opioid Induced Constipation SWOT Analysis
Table 55. Bayer Recent Developments
Table 56. Sanofi Opioid Induced Constipation Basic Information
Table 57. Sanofi Opioid Induced Constipation Product Overview
Table 58. Sanofi Opioid Induced Constipation Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. Sanofi Business Overview
Table 60. Sanofi Opioid Induced Constipation SWOT Analysis
Table 61. Sanofi Recent Developments
Table 62. Mallinckrodt Opioid Induced Constipation Basic Information
Table 63. Mallinckrodt Opioid Induced Constipation Product Overview
Table 64. Mallinckrodt Opioid Induced Constipation Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Mallinckrodt Business Overview
Table 66. Mallinckrodt Opioid Induced Constipation SWOT Analysis
Table 67. Mallinckrodt Recent Developments
Table 68. Salix (Bausch Health) Opioid Induced Constipation Basic Information
Table 69. Salix (Bausch Health) Opioid Induced Constipation Product Overview
Table 70. Salix (Bausch Health) Opioid Induced Constipation Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Salix (Bausch Health) Business Overview
Table 72. Salix (Bausch Health) Opioid Induced Constipation SWOT Analysis
Table 73. Salix (Bausch Health) Recent Developments
Table 74. AstraZeneca Opioid Induced Constipation Basic Information
Table 75. AstraZeneca Opioid Induced Constipation Product Overview
Table 76. AstraZeneca Opioid Induced Constipation Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Recent Developments
Table 79. Progenics Pharmaceuticals Opioid Induced Constipation Basic Information
Table 80. Progenics Pharmaceuticals Opioid Induced Constipation Product Overview
Table 81. Progenics Pharmaceuticals Opioid Induced Constipation Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Progenics Pharmaceuticals Business Overview
Table 83. Progenics Pharmaceuticals Recent Developments
Table 84. Purdue Pharm Opioid Induced Constipation Basic Information
Table 85. Purdue Pharm Opioid Induced Constipation Product Overview
Table 86. Purdue Pharm Opioid Induced Constipation Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Purdue Pharm Business Overview
Table 88. Purdue Pharm Recent Developments
Table 89. Nektar Therapeutics Opioid Induced Constipation Basic Information
Table 90. Nektar Therapeutics Opioid Induced Constipation Product Overview
Table 91. Nektar Therapeutics Opioid Induced Constipation Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Nektar Therapeutics Business Overview
Table 93. Nektar Therapeutics Recent Developments
Table 94. Daiichi Sankyo Opioid Induced Constipation Basic Information
Table 95. Daiichi Sankyo Opioid Induced Constipation Product Overview
Table 96. Daiichi Sankyo Opioid Induced Constipation Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Daiichi Sankyo Business Overview
Table 98. Daiichi Sankyo Recent Developments
Table 99. Prestige Opioid Induced Constipation Basic Information
Table 100. Prestige Opioid Induced Constipation Product Overview
Table 101. Prestige Opioid Induced Constipation Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Prestige Business Overview
Table 103. Prestige Recent Developments
Table 104. GSK Opioid Induced Constipation Basic Information
Table 105. GSK Opioid Induced Constipation Product Overview
Table 106. GSK Opioid Induced Constipation Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. GSK Business Overview
Table 108. GSK Recent Developments
Table 109. Shionogi Opioid Induced Constipation Basic Information
Table 110. Shionogi Opioid Induced Constipation Product Overview
Table 111. Shionogi Opioid Induced Constipation Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Shionogi Business Overview
Table 113. Shionogi Recent Developments
Table 114. Global Opioid Induced Constipation Sales Forecast by Region (K Units)
Table 115. Global Opioid Induced Constipation Market Size Forecast by Region (M USD)
Table 116. North America Opioid Induced Constipation Sales Forecast by Country (2022-2028) & (K Units)
Table 117. North America Opioid Induced Constipation Market Size Forecast by Country (2022-2028) & (M USD)
Table 118. Europe Opioid Induced Constipation Sales Forecast by Country (2022-2028) & (K Units)
Table 119. Europe Opioid Induced Constipation Market Size Forecast by Country (2022-2028) & (M USD)
Table 120. Asia Pacific Opioid Induced Constipation Sales Forecast by Region (2022-2028) & (K Units)
Table 121. Asia Pacific Opioid Induced Constipation Market Size Forecast by Region (2022-2028) & (M USD)
Table 122. South America Opioid Induced Constipation Sales Forecast by Country (2022-2028) & (K Units)
Table 123. South America Opioid Induced Constipation Market Size Forecast by Country (2022-2028) & (M USD)
Table 124. Middle East and Africa Opioid Induced Constipation Consumption Forecast by Country (2022-2028) & (Units)
Table 125. Middle East and Africa Opioid Induced Constipation Market Size Forecast by Country (2022-2028) & (M USD)
Table 126. Global Opioid Induced Constipation Sales Forecast by Type (2022-2028) & (K Units)
Table 127. Global Opioid Induced Constipation Market Size Forecast by Type (2022-2028) & (M USD)
Table 128. Global Opioid Induced Constipation Price Forecast by Type (2022-2028) & (USD/Unit)
Table 129. Global Opioid Induced Constipation Sales (K Units) Forecast by Application (2022-2028)
Table 130. Global Opioid Induced Constipation Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Opioid Induced Constipation
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Opioid Induced Constipation Market Size (M USD), 2017-2028
Figure 5. Global Opioid Induced Constipation Market Size (M USD) (2017-2028)
Figure 6. Global Opioid Induced Constipation Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Opioid Induced Constipation Market Size (M USD) by Country (M USD)
Figure 11. Opioid Induced Constipation Sales Share by Manufacturers in 2020
Figure 12. Global Opioid Induced Constipation Revenue Share by Manufacturers in 2020
Figure 13. Opioid Induced Constipation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Opioid Induced Constipation Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Opioid Induced Constipation Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Opioid Induced Constipation Market Share by Type
Figure 18. Sales Market Share of Opioid Induced Constipation by Type (2017-2022)
Figure 19. Sales Market Share of Opioid Induced Constipation by Type in 2021
Figure 20. Market Size Share of Opioid Induced Constipation by Type (2017-2022)
Figure 21. Market Size Market Share of Opioid Induced Constipation by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Opioid Induced Constipation Market Share by Application
Figure 24. Global Opioid Induced Constipation Sales Market Share by Application (2017-2022)
Figure 25. Global Opioid Induced Constipation Sales Market Share by Application in 2021
Figure 26. Global Opioid Induced Constipation Market Share by Application (2017-2022)
Figure 27. Global Opioid Induced Constipation Market Share by Application in 2020
Figure 28. Global Opioid Induced Constipation Sales Growth Rate by Application (2017-2022)
Figure 29. Global Opioid Induced Constipation Sales Market Share by Region (2017-2022)
Figure 30. North America Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Opioid Induced Constipation Sales Market Share by Country in 2020
Figure 32. U.S. Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Opioid Induced Constipation Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Opioid Induced Constipation Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Opioid Induced Constipation Sales Market Share by Country in 2020
Figure 37. Germany Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Opioid Induced Constipation Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Opioid Induced Constipation Sales Market Share by Region in 2020
Figure 44. China Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Opioid Induced Constipation Sales and Growth Rate (K Units)
Figure 50. South America Opioid Induced Constipation Sales Market Share by Country in 2020
Figure 51. Brazil Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Opioid Induced Constipation Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Opioid Induced Constipation Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Opioid Induced Constipation Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Opioid Induced Constipation Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Opioid Induced Constipation Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Opioid Induced Constipation Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Opioid Induced Constipation Market Share Forecast by Type (2022-2028)
Figure 65. Global Opioid Induced Constipation Sales Forecast by Application (2022-2028)
Figure 66. Global Opioid Induced Constipation Market Share Forecast by Application (2022-2028)
Keyplayers in Global Opioid Induced Constipation Market Research Report 2022(Status and Outlook)
•Takeda Pharmaceuticals•Bayer
•Sanofi
•Mallinckrodt
•Salix (Bausch Health)
•AstraZeneca
•Progenics Pharmaceuticals
•Purdue Pharm
•Nektar Therapeutics
•Daiichi Sankyo
•Prestige
•GSK
•Shionogi
Request Sample
Request Discount
